ID,Sex,Age,SCL (year),Side of Onset,Asymetry Index,Disease's Duration (year),L-DOPA Daily dose (Eq-DOPA),UPDRS3 off DOPA,UPDRS3 on Dopa,MDRS,Stroop I,TMT B-A,MCST C,MCST E,MCST P,MADRS,AES
1,F,61,12,L,−2,5,2057.5,32,8,144,4.62,26,4,15,5,3,23
2,F,54,6,R,−1.5,15,400,53,18,139,−14.73,102,3,19,5,20,48
3,F,63,12,R,3.5,7,650,36,17,144,13.36,47,6,7,3,5,37
4,M,61,14,L,−6,8,1450,48,22,136,1.06,86,6,4,1,0,23
5,M,53,14,L,−6.5,6,1740,41,17,138,−12.52,NC,6,0,0,10,25
6,M,61,6,R,2.5,6,1887.5,28,6,141,−2.17,24,6,5,3,5,34
7,F,46,12,L,−10,10,300,25,7,134,−1.67,31,6,2,0,1,34
8,F,55,9,L,−8.5,9,1150,55,30,142,−4.40,40,6,1,1,1,33
9,M,50,14,L,−14.5,7,637.5,34,8,144,2.29,13,6,2,0,0,26
10,M,43,14,R,4,9,100,31,3,137,3.37,35,6,4,0,3,24
11,M,52,15,L,−1.5,4,375,52,24,142,5.56,33,6,0,0,14,46
12,F,58,7,L,−3,10,715,48,19,143,1.82,NC,5.8,9,4,3,29
13,F,43,6,R,10,11,410,NC,NC,141,7.04,38,6,0,0,8,27
14,F,50,10,R,2,8,1517.5,30,11,141,−1.59,31,6,0,0,8,33
